Tag: Bharat Biotech
Telangana Court Orders Leftist Media ‘The Wire’ To Take Down 14 Articles Against Bharat Biotech And Covaxin, Not To Publish Any More Defamatory Reports
A court in Telangana has ordered leftist propaganda portal The Wire to take down as many as 14 articles it had published against Indian pharmaceutical company Bharat Biotech and the Covid-19 vaccine Covaxin developed by it. The order was passed after Bharat Biotech had filed… Read More
Covaxin Booster Shown To Neutralise Both Omicron And Delta Variants Of COVID-19: Bharat Biotech
Hyderabad-based Bharat Biotech on Wednesday (12 January) said that the booster dose of its COVAXIN Covid-19 vaccine neutralises both Omicron and Delta variants of the Coronavirus. "Booster dose of COVAXIN generated robust neutralizing antibody responses against both Omicron and Delta," the company said in a… Read More
Leave a Reply
‘Please Be Responsible’: Bharat Biotech ‘Fact-checks’ TOI, Wire And Others Who Have Spread Lies Against Covaxin
India’s vaccination drive has been reliant on two ‘Made In India’ vaccines, which are Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin. While SII’s Covishield is developed by Oxford AstraZeneca, Bharat Biotech’s Covaxin has been developed indigenously and has been India’s success story in… Read More
Leave a Reply
Australia Recognises Bharat Biotech’s Covaxin For Travellers Visiting The Country
On November 1, the Australian Government’s Therapeutic Goods Administration (TGA) under the Department of Health recognized made-in-India Covid-19 vaccine Covaxin by Bharat Biotech to establish a traveller’s vaccination status. The recognition has been approved for anyone of age 12 and above who have been vaccinated… Read More
Leave a Reply
GSK-Bharat Biotech Partnership To Produce World’s First Malaria Vaccine Approved By WHO
World Health Organization approved world's first vaccine against the mosquito-borne disease malaria - RTS,S/AS01. In January this year, GSK, PATH, and Indian vaccine maker Bharat Biotech (BBIL) announced the signing of a product transfer agreement for the malaria vaccine, RTS,S/AS01. . Read more at: https://swarajyamag.com/analysis/gsk-bharat-biotech-partnership-to-produce-worlds-first-malaria-vaccine-approved-by-who… Read More
Leave a Reply
Bharat Biotech’s Krishna Ella Says Company Working On A Combo Of Covaxin And Nasal Vaccine For Booster Dose
While the debate over a third Covid-19 vaccine shot is still going on between experts and pharmaceutical companies, the chairman and managing director of Indian Covid-19 vaccine maker Bharat Biotech, Dr Krishna Ella, said that the company is working on a combination of Covaxin and… Read More
Leave a Reply
Bharat Biotech Ltd Clarifies, Covaxin Is Highly Purified And Contains Only Inactive Virus Components
Bharat Biotech Limited today clarified that Covaxin is highly purified and contains only the inactive virus components. The company has issued the clarification over the use of new-born calf serum in the vaccine, the company has issued the clarification. The Hyderabad-based vaccine manufacturer responded to… Read More
Leave a Reply
CISF Takes Over Security Of Covaxin Manufacturer Bharat Biotech’s Hyderabad Campus
The Central Industrial Security Force (CISF) took over the security of vaccine manufacturer Bharat Biotech's premises in Hyderabad on Monday to protect it against any terror threat or sabotage that may lead to a biological disaster. A contingent of 6https://www.republicworld.com/india-news/general-news/cisf-takes-over-security-of-covaxin-manufacturer-bharat-biotechs-hyderabad-campus.html4 personnel, headed by an inspector-rank… Read More
Leave a Reply
Covaxin Phase 3 Trial Data In July; 100% Effective Against Hospitalisations; Phase 4 Next
Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial, will publish the data in July, and following that the company will be applying for the full licensure for Covaxin. Speaking about Covaxin's efficacy, Bharat Biotech said that the efficacy data of… Read More
Leave a Reply
After US, Bharat Biotech to Manufacture Covaxin in Canada
Hyderabad: India’s first indigenous COVID-19 vaccine ‘Covaxin’ will now be sold and manufactured in Canada as Bharat Biotech has extended its tie-up with biopharmaceutical company Ocugen Inc to expand to the Canadian market after the US. Bharat Biotech will have exclusive co-development, manufacturing, and commercialisation rights… Read More
Leave a Reply
Bharat Biotech’s Covaxin Shows 78 Percent Efficacy In Phase 3 Analysis
The final phase 3 analysis of Covaxin, the Covid-19 jab developed by Bharat Biotech, has shown the efficacy of 78 per cent in preventing symptomatic coronavirus caused disease, a report said. . Read more at: https://swarajyamag.com/news-brief/bharat-biotechs-covaxin-shows-78-percent-efficacy-in-phase-3-analysis . Read More
